Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

TYO/4882 stock hub

TYO/4882 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TYO/4882is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.3B

Tokyo Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TYO/4882

In the news

Latest news · TYO/4882

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.7P50 15.8P75 21.7

Trailing P/En/a

P25 11.7P50 15.2P75 22.3

ROEn/a

P25 -1.6P50 7.1P75 11.9

ROICn/a

P25 -0.6P50 6.2P75 14.3

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TYO/4882 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

155

Groups with data

Currency

JPY

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	JP
Employees	32
Employees Change	7%
Employees Change Percent	28
Enterprise value	JPY 2B
Exchange	Tokyo Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	JP3836800007
Last refreshed	2026-05-10
Market cap	JPY 3.3B
Price	JPY 217
Price currency	JPY
Rev Per Employee	4,387,750x
Sector	Healthcare
Sic	2836
Symbol	tyo/4882
Website	https://www.ppmx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-23.21%
EV Earnings	-2.68x
EV/Sales	14.46x
P/B ratio	3.69x
P/S ratio	23.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	86.21%
Gross Profit	JPY 121.1M
Gross Profit Growth	27.29%
Gross Profit Growth Q	81.81%
Gross Profit Growth3 Y	13.86%
Gross Profit Growth5 Y	-13.91%
Net Income	JPY -758.1M
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Pretax Margin	-538.47%
Profit Per Employee	JPY -23.7M
Roa5y	-22.97
ROCE	-63.03
Roe5y	-46.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-46.44%
Cagr3y	-8.9%
EPS Growth Quarters	5
EPS Growth Years	1
Revenue Growth	26.06x
Revenue Growth Q	82.02x
Revenue Growth Quarters	1x
Revenue Growth Years	4x
Revenue Growth3 Y	15.55x
Revenue Growth5 Y	-12.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	JPY 0.08
Assets	JPY 1.3B
Cash	JPY 1.2B
Current Assets	JPY 1.3B
Current Liabilities	JPY 101.3M
Equity	JPY 884.6M
Liabilities	JPY 437.9M
Long Term Assets	JPY 14.7M
Long Term Liabilities	JPY 336.6M
Net Cash	JPY 1.2B
Net Cash By Market Cap	JPY 37.84
Net Cash Growth	-34.23%
Net Debt Equity	JPY -1.4
Tangible Book Value	JPY 884.6M
Tangible Book Value Per Share	JPY 59.98
WACC	6.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	12.91
Inventory Turnover	3.42
Net Working Capital	JPY -29.2M
Quick ratio	12.67
Working Capital	JPY 1.2B
Working Capital Turnover	JPY 0.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-46.42%
200-day SMA	291.2
3Y total return	-24.39%
50-day SMA	232.4
50-day SMA vs 200-day SMA	50under200
All Time High	1,113
All Time High Change	-80.5%
All Time High Date	2025-03-25
All Time Low	203
All Time Low Change	6.9%
All Time Low Date	2025-12-22
ATR	8.74
Beta	0.37
Beta1y	0.33
Beta2y	1.22
Ch YTD	-3.13
High	217
High52	478
High52 Date	2025-06-02
High52ch	-54.6%
Low	213
Low52	203
Low52 Date	2025-12-22
Low52ch	6.9%
Ma50ch	-6.63%
Price vs 200-day SMA	-25.47%
RSI	43.32
RSI Monthly	38.91
RSI Weekly	38.03
Sharpe ratio	-0.83x
Sortino ratio	-1.09
Total Return	-0.03%
Tr YTD	-3.13
Tr1m	-8.44%
Tr1w	0.93%
Tr3m	-8.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	JPY -769.7M
Operating margin	-548.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,653,940%
Shares Insiders	1.06%
Shares Institutions	8.13%
Shares Out	15,049,550
Shares Qo Q	0%
Shares Yo Y	0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	245,145x
Bv Per Share	59.98
Ch1m	-8.44
Ch1w	0.93
Ch1y	-46.42
Ch3m	-8.82
Ch3y	-24.39
Ch6m	-25.43
Change	1.88%
Change From Open	1.4
Close	213
Days Gap	0.47
Depreciation Amortization	1,250,000
Dollar Volume	30,466,800
Earnings Date	2026-05-14
EBIT	JPY -769.7M
EPS	JPY -51.41
F Score	1
Fiscal Year End	March
Founded	2,001
Income Tax	JPY 2.1M
Is Primary Listing	1
Last Earnings Date	2026-02-13
Last Report Date	2025-12-31
Ma150	261.5
Ma150ch	-17.03%
Ma20	228.7
Ma20ch	-5.1%
Next Earnings Date	2026-05-14
Open	214
Position In Range	100
Price Date	2026-05-08
Ptbv Ratio	3.69
Relative Volume	0.57x
Revenue	140,408,000x
Tax By Revenue	1.47x
Tr6m	-25.43%
Volume	140,400
Z Score	7.47

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TYO/4882 pay a dividend?

Capital-return profile for this ticker.

Performance

TYO/4882 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TYO/4882?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.1%

Share of float held by funds and institutions

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

TYO/4882 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.3

Neutral momentum band

Price vs 200-day MA

-25.5%

50/200-day relationship not available

Beta (5Y)

0.37

Less volatile than the market

Sharpe ratio

-0.83

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TYO/4882

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/4882 stock rating?

tyo/4882 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/4882 analysis?

The full report lives at /stocks/tyo/4882/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/4882?

The latest report frames tyo/4882 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/4882 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.